SCR-LIP-000644 · Claim · machine-readable JSON →
Circulating testosterone and estradiol are reported not to differ between women with lipedema and controls, though evidence is limited.
General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- high (GRADE)
- Evidence
- 1 source(s)
- Answers
- 2 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (1)
- Auf der Suche nach der Evidenz: Eine systematische Übersichtsarbeit zur Pathologie des Lipödems — Funke et al. (2023) ✓ verified — consistent · meta analysis · 2023 · reading confidence: high
PRISMA systematic review of lipedema pathology: testosterone and estradiol showed no significant difference versus controls in plasma; etiology remains largely uncertain despite near-exclusive female occurrence.
The systematic review (PRISMA-based) addresses lipedema pathogenesis broadly, noting the near-exclusive female prevalence (suggesting hormonal influence) but finding no significant difference in testosterone or estradiol levels versus contr
Context (PECO)
Answers these questions
- Do hormones and heredity influence the onset of lipedema? refining
- Do hormonal factors (puberty, pregnancy, menopause, estrogen) trigger or influence lipedema onset? refining
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000012